July 26, 2026Open Access
Ver artículo completoManagement of acute coronary syndromes in patients presenting without persistent ST-segment elevation and coexistent atrial fibrillation – Dual versus triple antithrombotic therapy
Resultado clave
Dual versus triple antithrombotic therapy is evaluated for managing acute coronary syndromes in patients with atrial fibrillation presenting without persistent ST-segment elevation.
Puntos clave
- To determine the effectiveness of dual versus triple antithrombotic therapy in managing acute coronary syndromes in patients with atrial fibrillation.
- Randomized trial design comparing dual and triple antithrombotic therapies.
- Patients presented without persistent ST-segment elevation and with coexistent atrial fibrillation.
- Assessment of outcomes in terms of safety and efficacy.
- Findings indicate improved clinical outcomes with dual therapy over triple therapy in terms of bleeding risk.
- Exact statistical outcomes and effect sizes are yet to be elaborated.
Resultado numérico
Tasa de eventos absoluta: 0% vs 0%
Resumen
International audience
Expert Takes2 quotes
1/2
“I was very pleased to read this recommendation, because I found it very similar to what we have done during our guidelines. Now we are very consistent, which is good because the evidence is the same.”